LONDON (AP) — The drugmaker Shire PLC plans to reinforce its rare disease remedy portfolio via spending $four.2 billion in cash to buy the biopharmaceutical company ViroPharma Inc.
Shire buys ViroPharma in $4.2 billion deal
Posted by admin /
Posted by admin /
LONDON (AP) — The drugmaker Shire PLC plans to reinforce its rare disease remedy portfolio via spending $four.2 billion in cash to buy the biopharmaceutical company ViroPharma Inc.
Copyright © 2024 USA Closer – USA Breaking News | World, Business, Sports, Entertainment and Video News. All rights reserved. URLrate